AKT1 and colorectal carcinoma: Ti3C2-BiVO4 nanosheets also affect key signalling pathways of CRC progression, including PI3K/AKT/mTOR, MAPK/ERK, and Wnt/β-catenin, leading to decreased CRC cell motility, invasion, and survival.